Home » Stocks » OBLN

Obalon Therapeutics, Inc. (OBLN)

Stock Price: $2.39 USD -0.20 (-7.72%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $2.46 +0.07 (2.93%) May 14, 7:59 PM
Market Cap 23.95M
Revenue (ttm) 808,000
Net Income (ttm) -11.24M
Shares Out 9.44M
EPS (ttm) -1.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $2.39
Previous Close $2.59
Change ($) -0.20
Change (%) -7.72%
Day's Open 2.57
Day's Range 2.35 - 2.68
Day's Volume 836,627
52-Week Range 0.66 - 10.77

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other stocks mentioned: EVFM, NERV, NOVN
3 days ago - PennyStocks

SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intra...

3 days ago - GlobeNewsWire

SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN) is urging its stockholders to IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at th...

3 days ago - Accesswire

Before investing in penny stocks, take a look at these 3 things The post Investing in Penny Stocks? Don't Before You Do These 3 Things appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other stocks mentioned: TMBR, TTI
4 days ago - PennyStocks

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other stocks mentioned: IBIO, PRPO, PTIX
5 days ago - PennyStocks

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...

Other stocks mentioned: APOP, CKX, CUE, ELTK, LEDS, PRPO, PTE ...
5 days ago - InvestorPlace

Reddit penny stocks remain popular, here's 3 to watch The post Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks...

Other stocks mentioned: BBIG, FRSX
3 weeks ago - PennyStocks

Penny stocks are benefitting from the cryptocurrency boom; here's 3 to watch The post Penny Stocks to Buy During the Cryptocurrency Boom? Here's 3 to Watch appeared first on Penny Stocks to Buy, Picks, ...

Other stocks mentioned: MOXC, SEAC
3 weeks ago - PennyStocks

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled int...

2 months ago - GlobeNewsWire

WILMINGTON, Del., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Obalon Therapeutics, Inc. (“Obalon”) (NASDAQ GS: OBLN) regarding possible breaches of fiduciary...

3 months ago - GlobeNewsWire

NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Act...

3 months ago - PRNewsWire

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Obalon Therapeut...

3 months ago - Business Wire

NEW YORK, Jan. 21, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. ("Obalon" or ...

3 months ago - PRNewsWire

Genetic Technologies (NASDAQ: GENE) shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alone...

Other stocks mentioned: ADXN, GENE
3 months ago - Benzinga

Shares of medical technology company Obalon Therapeutics exploded 568% to as high as $10.71 on Wednesday following a merger announcement with weight-loss company ReShape Lifesciences. Obalon's stock rea...

3 months ago - Business Insider

Obalon Therapeutics Inc (NASDAQ: OBLN) shares are trading higher Wednesday after the company announced a merger agreement with ReShape Lifesciences. Obalon Therapeutics is a medical device company that ...

3 months ago - Benzinga

Shares of Obalon Therapeutics Inc. blasted five-fold higher on massive volume in midday trading Wednesday, after the weight loss technologies company announced an agreement to merge with weight loss sol...

3 months ago - Market Watch

Obalon Therapeutics (OBLN) stock is skyrocketing on Wednesday after announcing merger plans with ReShape Lifesciences (RSLS). The post OBLN Stock: 12 Things to Know About the ReShape-Obalon Merger as Sh...

3 months ago - InvestorPlace

Obalon Therapeutics (OBLN) stock is skyrocketing higher Monday on heavy trading despite a lack of news from the medical device company. The post OBLN Stock: 11 Things to Know About Weight Loss Balloon P...

5 months ago - InvestorPlace

Obalon Therapeutics's (NASDAQ: OBLN) stock has been rising Monday, up 121.49% to a price of $1.9. The stock's volume is currently 17.38 million, which is roughly 1879.95% of its recent 30-day volume ave...

5 months ago - Benzinga

After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

5 months ago - Insider Monkey

SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intr...

6 months ago - GlobeNewsWire

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon...

9 months ago - GlobeNewsWire

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled in...

9 months ago - GlobeNewsWire

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon...

10 months ago - GlobeNewsWire

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN ), a vertically integrated weight loss solutions company commercializing the first and o...

1 year ago - GlobeNewsWire

Obalon’s Executive Chairman, Andy Rasdal, will reassume CEO position Obalon’s Executive Chairman, Andy Rasdal, will reassume CEO position

1 year ago - GlobeNewsWire

Obalon reported no device-related serious adverse events (0%) for first 141 patients completing therapy in post-approval study to FDA Obalon reported no device-related serious adverse events (0%) for fi...

1 year ago - GlobeNewsWire

SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowab...

1 year ago - GlobeNewsWire

No patients or employees have been found to be symptomatic or positive for the virus, yet patient, employee, and public health remain Obalon’s highest priority No patients or employees have been found t...

1 year ago - GlobeNewsWire

Obalon Therapeutics, Inc. (OBLN) CEO Bill Plovanic on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Company continues to execute on its strategy to develop retail treatment sites focused exclusively on treatment with the Obalon Balloon System™ Company continues to execute on its strategy to develop re...

1 year ago - GlobeNewsWire

SAN DIEGO, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowabl...

1 year ago - GlobeNewsWire

Is (OBLN) Outperforming Other Medical Stocks This Year?

1 year ago - Zacks Investment Research

SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable, gas-fill...

1 year ago - GlobeNewsWire

Obalon Therapeutics, Inc. (OBLN) Management on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of 82.57% and -84.86%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

OBALON THERPTCS (OBLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Solidified leadership and strengthened financial position in place to leverage the Company’s safe and effective weight loss system in the retail medicine setting Solidified leadership and strengthened f...

1 year ago - GlobeNewsWire

SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intra-gastric ballo...

1 year ago - GlobeNewsWire

Shares of Obalon Therapeutics Inc (NASDAQ: OBLN), a developer of novel technologies for weight loss, were advancing strongly Thursday morning.

1 year ago - Benzinga

Leading bariatric surgeon and authority in the field to oversee medical activities for the Obalon Center for Weight Loss located in San Diego, CA. Leading bariatric surgeon and authority in the field to...

1 year ago - GlobeNewsWire

Obalon Therapeutics Inc (OBLN) Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

OBALON THERPTCS (OBLN) delivered earnings and revenue surprises of 7.41% and -78.79%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Shares of micro-cap Obalon Therapeutics Inc (NASDAQ: OBLN) traded higher Tuesday after the company announced it has obtained two new U.S.

1 year ago - Benzinga

Shares of micro-cap Obalon Therapeutics (traded higher after traders circulated the U.S. patent and trademark office abstract for its Intragastric device.

1 year ago - Benzinga

Obalon Therapeutics Inc (NASDAQ: OBLN) shares have continued to be volatile — and that's no surprise, given that most low-float, low-volume stocks are susceptible to trader manipulation.

1 year ago - Benzinga

Obalon Therapeutics Inc. shares rose 60 percent Wednesday morning, triggered by a Seeking Alpha post that said Johnson & Johnson could be making a bid for the company for $8 per share.

1 year ago - Benzinga

In the latest trading session, OBALON THERPTCS (OBLN) closed at $0.68, marking a -0.37% move from the previous day.

1 year ago - Zacks Investment Research

About OBLN

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; ... [Read more...]

Industry
Medical Devices
IPO Date
Oct 6, 2016
CEO
Andrew Rasdal
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
OBLN
Full Company Profile

Financial Performance

In 2020, OBLN's revenue was $1.59 million, a decrease of -51.60% compared to the previous year's $3.28 million. Losses were -$12.33 million, -47.91% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for OBLN stock is "Hold" and the 12-month stock price forecast is 6.15.

Price Target
$6.15
Analyst Consensus: Hold